• Fri news: Pfizer’s $1B Chinese commitment. RFK Jr. and pharma. Eisai dials back Leqembi forecast. US diabetes burden increase. JNJ gets Varipulse approval. See more on our front page

Karyopharm - oncology





Only reps who are desperate (e.g. Amgen, Pfizer) accepted offers for "Krazypharm". Feel sorry for anyone who has to work for Derek Waters. Extremely inexperienced. That's why he hired reps with no myeloma experience. He's an insecure manager who doesn't want anyone to know more than him. Mission accomplished.
 












































I am not sure the drug doesn't get approved. However, you need to have academic centers who have used the drug in trials. If you have a community based geography you have to look to leave immediately. Good luck